Inclusion Criteria:

- Postmenopausal women with hormone receptor-positive breast cancer:

- Recurrence after the adjuvant hormone therapy;

- Or initially inoperable locally advanced or metastatic breast cancer progressed after
the first line hormone therapy;

- Ability to read and write and complete questionnaires Provision of written informed
consent

- Patients who have already been prescribed therapy with the above-mentioned lines and
who can continue on the prescribed therapy in the investigator's opinion according to
his/her regular clinical practice and cure

Exclusion Criteria:

- As per study design, to ensure high validity of data and to obtain accurate
information on real-life practice,

- Patients currently participating in other clinical studies will not be included in
this study